stenting

Network Meta-Analysis of Complementary Imaging (IVUS/OCT + Conventional Angiography) for Coronary Stenting

Complementary imaging allows for the identification of numerous scenarios not visible with conventional angiography (ICA), both for the assessment of differential diagnoses and the improvement of percutaneous coronary intervention (PCI) outcomes. Advantages include assessment of plaque characteristics, vessel plaque burden, stent edge dissection, vessel diameter, and correct apposition, among others. While intravascular ultrasound (IVUS) was<a href="https://solaci.org/en/2024/02/28/network-meta-analysis-of-complementary-imaging-ivus-oct-conventional-angiography-for-coronary-stenting/" title="Read more" >...</a>

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejas

Provisional Stenting vs. Culotte: 5-Year Results of EBC TWO

The optimal treatment of true bifurcation lesions not affecting the left main coronary artery is widely debated. Results from randomized studies have shown neutral or worse outcomes with the two-stent technique. Regarding these studies, researchers used first-generation stents and the secondary branches were small. The EBC TWO study compared the provisional stenting strategy against the<a href="https://solaci.org/en/2023/05/29/provisional-stenting-vs-culotte-5-year-results-of-ebc-two/" title="Read more" >...</a>

EuroPCR 2023 | Provisional Stenting is Still the First Choice

The EBC TWO in Non-LM study randomized 200&nbsp;patients with bifurcation lesions not affecting the left main coronary artery (LCA) to receive provisional stenting vs. culotte (Norobi stent). The secondary branch had to have a diameter ≥2.5&nbsp;mm and a lesion length &gt;5&nbsp;mm. The crossover of those who received provisional stenting to the two-stent strategy was 16%.<a href="https://solaci.org/en/2023/05/21/europcr-2023-provisional-stenting-is-still-the-first-choice/" title="Read more" >...</a>

EuroPCR 2023 |Chimney Stenting vs BASILICA for the Prevention of Coronary Obstruction during TAVR

Coronary obstruction is a complication from TAVR that can cause death (up to 50% mortality), even though its incidence is lower than 1%.&nbsp; One of the most frequent strategies used in the prevention of this complication is chimney stenting in patients at high anatomical risk (valve in valve, narrow sinotubular junction, short coronary ostium height).<a href="https://solaci.org/en/2023/05/17/europcr-2023-chimney-stenting-vs-basilica-for-the-prevention-of-coronary-obstruction-during-tavr/" title="Read more" >...</a>

EuroPCR 2023 | KISS: Provisional Stenting in Bifurcations

Provisional stenting is the most frequent strategy and the most recommended in the treatment of bifurcations, even though in some situations the two-step&nbsp;kiss technique is prioritized, seeing as it offers the benefit of better rheology, less side branch occlusion, less periprocedural injury, better angina control and less restenosis.&nbsp; It included patients with de novo bifurcation<a href="https://solaci.org/en/2023/05/17/europcr-2023-kiss-provisional-stenting-in-bifurcations/" title="Read more" >...</a>

EuroPCR 2023 | EBC Two – Provisional Stenting vs Culotte in Bifurcations

MD Sandeep Arunothayaraj presented the 5-year followup of EBC Two (which had not previously shown significant differences in clinical outcomes at 12 months) in patients randomized to provisional stenting vs. systematic culotte in bifurcations that were not left main.&nbsp; The study followed up 200 patients with true bifurcations, side branch ≥2.5mm and lesion length ≥5mm,<a href="https://solaci.org/en/2023/05/17/europcr-2023-ebc-two-provisional-stenting-vs-culotte-in-bifurcations/" title="Read more" >...</a>

Síndrome de Tokotsubo ¿El género tiene influencia en su pronóstico?

Plaque Erosion with No Stenting in Acute Coronary Syndrome: Are There Event Predictors to Avoid This Strategy?

&nbsp;Event predictors in patients with plaque erosion and no stenting. A third of all acute coronary syndrome (ACS) cases are caused by plaque erosion. In the initial EROSION study, it was shown that patients with plaque erosion (as evidenced by OCT, with stenosis &lt;70%, TIMI III flow, and asymptomatic) were stabilized without stent implantation (no<a href="https://solaci.org/en/2023/02/13/plaque-erosion-with-no-stenting-in-acute-coronary-syndrome-are-there-event-predictors-to-avoid-this-strategy/" title="Read more" >...</a>

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejas

Three-Year Outcomes after CTA with 2-Stent Technique Vs. Provisional Stenting for Complex Bifurcation Lesions

The prevalence of coronary lesions with bifurcation involvement is about 20% in patients undergoing coronary angiography (CTA). While provisional stenting is overall the most accepted technique, the 2018 myocardial revascularization guidelines recommend the 2-stent technique for complex bifurcation lesions, defined as side branch with lesion &gt;5mm, distal reference diameter of the side branch ≥2.75, or<a href="https://solaci.org/en/2022/07/13/three-year-outcomes-after-cta-with-2-stent-technique-vs-provisional-stenting-for-complex-bifurcation-lesions/" title="Read more" >...</a>

Resonancia vs FFR en lesiones no culpables del infarto

OCT in STEMI Patients: Is It Safe to Prevent Stenting?

Percutaneous coronary intervention in patients with acute myocardial infarction (AMI) where the physiopathological mechanism is plaque erosion or non-atherosclerotic mechanisms (such as spontaneous coronary artery dissection) is not beneficial according to recent studies.&nbsp; The EROSION study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography–Based Management in Plaque Erosion) has shown medical treatment with no<a href="https://solaci.org/en/2022/04/20/oct-in-stemi-patients-is-it-safe-to-prevent-stenting/" title="Read more" >...</a>

ELUVIA: DES en territorio femoropoplíteo con lesiones complejas

Should We Start Stenting with DES in Femoropopliteal Territory?

Percutaneous intervention of femoropopliteal lesions have been the standard strategy these past two decades. The development of drug eluting stents (DES) or drug eluting balloons (DEB) has improved patency rate compared against conventional balloon angioplasty. The ILLUMINA -a multicenter study- looked into the polymer free self-expanding stent NiTiDES, which showed at 1 year an 87%<a href="https://solaci.org/en/2022/04/07/should-we-start-stenting-with-des-in-femoropopliteal-territory/" title="Read more" >...</a>

Top